Fol. Biol. 2004, 50, 200-202
https://doi.org/10.14712/fb2004050060200
The Role of NK1.1+ Cells in the Protection against MHC Class I+ HPV16-Associated Tumours
Individual author index pages
Other articles of these authors
-
Serum Levels of Matrix Metalloproteinases 2 and 9 in Patients with Acute Myocardial Infarction
Jana Šímová, J. Škvor, D. Slovák, I. Mazura, J. Zvárová
2013, Vol. 59, Issue 5, pp. 181-187 -
Serum Levels of Matrix Metalloproteinases 2 and 9 and TGFBR2 Gene Screening in Patients with Ascending Aortic Dilatation
Jana Šímová, J. Škvor, J. Reissigová, J. Dudra, J. Lindner, P. Čapek, J. Zvárová
2013, Vol. 59, Issue 4, pp. 154-161 -
Genetically Modified Vaccines Augment the Efficacy of Cancer Surgery and Chemotherapy
J. Bubeník
2009, Vol. 55, Issue 6, pp. 199-200 -
Immunotherapeutic Efficacy of Vaccines Generated by Fusion of Dendritic Cells and HPV16-Associated Tumour Cells
Jana Šímová, J. Bubeník, J. Bieblová, M. Indrová, T. Jandlová
2005, Vol. 51, Issue 1, pp. 19-24 -
Immunogenicity of Dendritic Cell-Based HPV16 E6/E7 Peptide Vaccines: CTL Activation and Protective Effects
Marie Indrová, M. Reiniš, J. Bubeník, T. Jandlová, J. Bieblová, V. Vonka, J. Velek
2004, Vol. 50, Issue 6, pp. 184-193
